DIA Pharmacovigilance and Risk Management Strategies 2017

Pharmacovigilance and risk management are key activities for ensuring that the right products get to patients at the right time with the right balance of benefits and risks. Optimizing benefit-risk is an important matter not just for regulators, but for all stakeholders, and planning for pharmacovigilance activities and appropriate evidence gathering must be done throughout the medicine life cycle. Against a backdrop of rapid therapeutic innovation, technologic advances, and widening choices of potential safety data sources and analytical methodologies, the pharmacovigilance and risk management of today demand ever smarter approaches.